Host-microbe co-metabolism dictates cancer drug efficacy in C. elegans TA Scott, LM Quintaneiro, P Norvaisas, PP Lui, MP Wilson, KY Leung, ... Cell 169 (3), 442-456. e18, 2017 | 207 | 2017 |
Host-microbe-drug-nutrient screen identifies bacterial effectors of metformin therapy R Pryor, P Norvaisas, G Marinos, L Best, LB Thingholm, LM Quintaneiro, ... Cell 178 (6), 1299-1312. e29, 2019 | 165 | 2019 |
Discovery and characterization of novel selective inhibitors of carbonic anhydrase IX V Dudutiene, J Matuliene, A Smirnov, DD Timm, A Zubriene, ... Journal of Medicinal Chemistry 57 (22), 9435-9446, 2014 | 87 | 2014 |
Intrinsic thermodynamics of 4-substituted-2, 3, 5, 6-tetrafluorobenzenesulfonamide binding to carbonic anhydrases by isothermal titration calorimetry A Zubrienė, J Smirnovienė, A Smirnov, V Morkūnaitė, V Michailovienė, ... Biophysical Chemistry 205, 51-65, 2015 | 54 | 2015 |
Thermodynamics of cationic and anionic surfactant interaction P Norvaišas, V Petrauskas, D Matulis The Journal of Physical Chemistry B 116 (7), 2138-2144, 2012 | 35 | 2012 |
Fine-tuning autophagy maximises lifespan and is associated with changes in mitochondrial gene expression in Drosophila I Bjedov, HM Cochemé, A Foley, D Wieser, NS Woodling, JI Castillo-Quan, ... PLoS genetics 16 (11), e1009083, 2020 | 31 | 2020 |
The role of payload hydrophobicity in nanotherapeutic pharmacokinetics P Norvaisas, A Ziemys Journal of pharmaceutical sciences 103 (7), 2147-2156, 2014 | 22 | 2014 |
WormJam: A consensus C. elegans Metabolic Reconstruction and Metabolomics Community and Workshop Series J Hastings, A Mains, M Artal-Sanz, S Bergmann, BP Braeckman, J Bundy, ... Worm 6 (2), e1373939, 2017 | 14 | 2017 |
Revisiting Santa Rosalia to unfold a degeneracy of classic models of speciation P Norvaišas, E Kisdi The American Naturalist 180 (3), 388-393, 2012 | 14 | 2012 |
High pressure spectrofluorimetry–a tool to determine protein-ligand binding volume G Skvarnavičius, Z Toleikis, M Grigaliūnas, J Smirnovienė, P Norvaišas, ... Journal of Physics: Conference Series 950 (4), 042001, 2017 | 8 | 2017 |
Pharmacology in the age of the holobiont P Norvaisas, F Cabreiro Current Opinion in Systems Biology 10, 34-42, 2018 | 7 | 2018 |
The protein kinase promiscuities in the cancer-preventive mechanisms of NSAIDs P Norvaisas, D Chan, K Yokoi, B Dave, A Ziemys European Journal of Cancer Prevention 25 (1), 77, 2016 | 2 | 2016 |
Prediction and analysis of drug delivery systems: from drug-vector compatibility to release kinetics P Norvaisas, M Kojic, M Milosevic, A Ziemys Scientifically speaking September, 14-15, 2013 | 2 | 2013 |
Interaction between host, microbiota, diet and drugs in C. elegans and E. coli P Norvaisas UCL (University College London), 2019 | | 2019 |
Intrinsic Thermodynamics-Structure Correlation of Carbonic Anhydrase Inhibitors D Matulis, A Zubrienė, L Baranauskienė, A Smirnov, V Morkūnaitė, ... Biophysical Journal 108 (2), 217a, 2015 | | 2015 |
Hydrophobic effect: Termodynamics of cationic & anionic surfactant interaction and laws of additivity in the structure-based drug design P Norvaišas Vilnius University, 2012 | | 2012 |
Optimizing drug delivery platforms by matching physico-chemical and pharmacokinetic properties of drugs and drug vectors P Norvaisas, A Ziemys | | |